{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:13:50Z","timestamp":1793834030422,"version":"4.6.1"},"reference-count":300,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by the degeneration of dopamine neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms. While motor symptoms such as rigidity, tremor, bradykinesia\/akinesia, and postural instability are well-recognized, non-motor symptoms including cognitive decline, depression, and anxiety also significantly impact patients' quality of life. Preclinical research utilizing animal models has been instrumental in understanding PD pathophysiology and exploring therapeutic interventions. Various approaches, including genetic manipulations and toxin-induced insults, aim to recapitulate both motor and non-motor aspects of PD in animal models. However, no single model fully replicates the complex spectrum of PD symptoms. Behavioral assessments play a crucial role in evaluating motor impairments in PD animal models, focusing on the manifestation of Parkinsonian motor phenotype. These assessments encompass locomotor activities, motor behavior abnormalities, and induced rotational behavior. Similarly, non-motor features are assessed through tests evaluating behavioral alterations such as depression, anxiety, and cognitive impairment. Although numerous animal models of PD have been developed, including non-human primates and both mammalian and non-mammalian species, this review focuses on motor and non-motor testing methodologies in rodent models, which are the most commonly used. Emphasizing genetic and toxin-induced PD models in mice and rats, we highlight key testing strategies and the significance of each method in addressing specific research questions and interpreting experimental data. By providing a comprehensive overview of these testing approaches, this review aims to advance understanding and foster progress in PD research.<\/jats:p>","DOI":"10.3389\/fnagi.2024.1464706","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:43:10Z","timestamp":1734918190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Razan","family":"Sheta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Musiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mart\u00ednez-Drudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nlm.2017.05.001","article-title":"Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice","volume":"142","author":"Adeosun","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbr.2003.08.014","article-title":"The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA","volume":"151","author":"Alam","year":"2004","journal-title":"Behav. Brain Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"B4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neurobiolaging.2008.11.001","article-title":"Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice","volume":"31","author":"Al-Wandi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/cjpp-2016-0158","article-title":"Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats","volume":"95","author":"Ameen","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-0003-2-20","article-title":"Gait dynamics in mouse models of Parkinson's disease and Huntington's disease","volume":"2","author":"Amende","year":"2005","journal-title":"J. Neuroeng. Rehabil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5214\/ans.0972-7531.1017304","article-title":"Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice","volume":"17","author":"Anandhan","year":"2010","journal-title":"Ann. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF03033150","article-title":"Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease","volume":"5","author":"Andersen","year":"2003","journal-title":"Neurotox. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","article-title":"Protective role of apigenin on rotenone induced rat model of Parkinson's disease: suppression of neuroinflammation and oxidative stress mediated apoptosis","volume":"269","author":"Anusha","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e42652","DOI":"10.1371\/journal.pone.0042652","article-title":"The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats","volume":"7","author":"Aristieta","year":"2012","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neurobiolaging.2017.06.008","article-title":"Absence of regulator of G-protein signaling 4 does not protect against dopamine neuron dysfunction and injury in the mouse 6-hydroxydopamine lesion model of Parkinson's disease","volume":"58","author":"Ashrafi","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2013.02.066","article-title":"The effect of dopamine on MPTP-induced rotarod disability","volume":"543","author":"Ayton","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3727\/096368916X693059","article-title":"Step sequence is a critical gait parameter of unilateral 6-OHDA Parkinson's rat models","volume":"26","author":"Baldwin","year":"2017","journal-title":"Cell Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1212\/01.WNL.0000036908.39696.FD","article-title":"Fluctuations in attention: PD dementia vs DLB with parkinsonism","volume":"59","author":"Ballard","year":"2002","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1460-9568.2010.07555.x","article-title":"Evaluating the neural basis of temporal order memory for visual stimuli in the rat","volume":"33","author":"Barker","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","article-title":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats","volume":"1593","author":"Bassani","year":"2014","journal-title":"Brain Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13024-023-00683-8","article-title":"Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains","volume":"18","author":"Berard","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e3001578","DOI":"10.1371\/journal.pbio.3001578","article-title":"A light-inducible protein clustering system for in vivo analysis of alpha-synuclein aggregation in Parkinson disease","volume":"20","author":"Berard","year":"2022","journal-title":"PLoS Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"109910","DOI":"10.1016\/j.jneumeth.2023.109910","article-title":"Rethinking data treatment: The sucrose preference threshold for anhedonia in stress-induced rat models of depression","volume":"395","author":"Berrio","year":"2023","journal-title":"J. Neurosci. Methods"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70249","DOI":"10.1371\/journal.pone.0070249","article-title":"Non-motor and motor features in LRRK2 transgenic mice","volume":"8","author":"Bichler","year":"2013","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/s41598-017-07181-0","article-title":"Mitochondrial division inhibitor-1 is neuroprotective in the A53T-alpha-synuclein rat model of Parkinson's disease","volume":"7","author":"Bido","year":"2017","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00702-017-1715-x","article-title":"The use of nonhuman primate models to understand processes in Parkinson's disease","volume":"125","author":"Blesa","year":"2018","journal-title":"J. Neural Transm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.expneurol.2009.05.017","article-title":"Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism","volume":"219","author":"Blume","year":"2009","journal-title":"Exp. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/9780470942390.mo140092","article-title":"Overview of mouse models of Parkinson's disease","volume":"4","author":"Bobela","year":"2014","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1742-2094-9-86","article-title":"Viral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat","volume":"9","author":"Bobyn","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbr.2015.01.053","article-title":"A partial lesion model of Parkinson's disease in mice\u2013characterization of a 6-OHDA-induced medial forebrain bundle lesion","volume":"284","author":"Boix","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fnbeh.2018.00039","article-title":"Gait analysis for early detection of motor symptoms in the 6-OHDA rat model of Parkinson's disease","volume":"12","author":"Boix","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","article-title":"Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression","volume":"3","author":"Bourdenx","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1038\/s41598-017-03336-1","article-title":"A translational approach to capture gait signatures of neurological disorders in mice and humans","volume":"7","author":"Broom","year":"2017","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"046110","DOI":"10.1242\/dmm.046110","article-title":"Modeling neurodegeneration in Caenorhabditiselegans","volume":"13","author":"Caldwell","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"B36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","article-title":"Rodent models of Parkinson's disease: beyond the motor symptomatology","volume":"7","author":"Campos","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/0471142301.ns0812s15","article-title":"Motor coordination and balance in rodents","volume":"8","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human alpha-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.t01-1-00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/0471142301.ns0925s41","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"9","author":"Cenci","year":"2007","journal-title":"Curr Protoc Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.nbd.2007.11.011","article-title":"Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function","volume":"29","author":"Chandran","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"B44","doi-asserted-by":"publisher","first-page":"21418","DOI":"10.1074\/jbc.M413955200","article-title":"Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson's disease: the Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of parkinson's disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","article-title":"Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson's disease","volume":"22","author":"Chinta","year":"2018","journal-title":"Cell Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","article-title":"Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats","volume":"20","author":"Cicchetti","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0892-0362(90)90061-G","article-title":"Effects of MPTP on locomotor activity in mice","volume":"12","author":"Colotla","year":"1990","journal-title":"Neurotoxicol. Teratol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-171258","article-title":"Modeling Parkinson's disease in C. elegans","volume":"8","author":"Cooper","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.877576","article-title":"Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity","volume":"197","author":"Creese","year":"1977","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/ejn.14683","article-title":"Characterization of a Parkinson's disease rat model using an upgraded paraquat exposure paradigm","volume":"52","author":"Cristovao","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1038\/s41598-024-54066-0","article-title":"Characterization of graded 6-hydroxydopamine unilateral lesion in medial forebrain bundle of mice","volume":"14","author":"Cui","year":"2024","journal-title":"Sci. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s11011-017-0060-y","article-title":"Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study","volume":"32","author":"Darbinyan","year":"","journal-title":"Metab. Brain Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pathophys.2017.01.001","article-title":"Rotenone impairs hippocampal neuronal activity in a rat model of Parkinson's disease","volume":"24","author":"Darbinyan","year":"","journal-title":"Pathophysiology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","article-title":"Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease","volume":"70","author":"Dave","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2609","DOI":"10.3791\/2609-v","article-title":"Measuring motor coordination in mice","volume":"75","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"B60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","article-title":"Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson's disease","volume":"235","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/medicina59101756","article-title":"Cognitive impairment in Parkinson's disease: an updated overview focusing on emerging pharmaceutical treatment approaches","volume":"59","author":"Degirmenci","year":"2023","journal-title":"Medicina"},{"key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1326-7-49","article-title":"Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's disease","volume":"7","author":"Desplats","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.3390\/s20123529","article-title":"Gait analysis in Parkinson's disease: an overview of the most accurate markers for diagnosis and symptoms monitoring","volume":"20","author":"Di Biase","year":"2020","journal-title":"Sensors"},{"key":"B64","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1474-4422(06)70549-X","article-title":"The mystery of motor asymmetry in Parkinson's disease","volume":"5","author":"Djaldetti","year":"2006","journal-title":"Lancet Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. Am. Pharm. Assoc."},{"key":"B66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0079-6123(10)84003-8","article-title":"Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease","volume":"184","author":"Dunnett","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e00915","DOI":"10.1002\/brb3.915","article-title":"Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"8","author":"Ekmark-Lewen","year":"2018","journal-title":"Brain Behav."},{"key":"B68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson's disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev. Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson's disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"659","DOI":"10.5114\/aoms.2017.67284","article-title":"Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity","volume":"13","author":"Essawy","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neures.2006.04.010","article-title":"The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats","volume":"55","author":"Fang","year":"2006","journal-title":"Neurosci. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","article-title":"A drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/neuro.07.003.2009","article-title":"Extracting kinematic parameters for monkey bipedal walking from cortical neuronal ensemble activity","volume":"3","author":"Fitzsimmons","year":"2009","journal-title":"Front. Integr. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"50303","DOI":"10.3791\/50303-v","article-title":"Assessment of sensorimotor function in mouse models of Parkinson's disease","volume":"76","author":"Fleming","year":"2013","journal-title":"J. Vis. Exp"},{"key":"B77","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"","journal-title":"J. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.neuroscience.2006.07.005","article-title":"Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein","volume":"142","author":"Fleming","year":"2006","journal-title":"Neuroscience"},{"key":"B79","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"","journal-title":"Exp. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"9124160","DOI":"10.1155\/2017\/9124160","article-title":"Depression in Parkinson's disease: the contribution from animal studies","volume":"2017","author":"Fontoura","year":"2017","journal-title":"Parkinsons Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02260967","article-title":"MPTP-induced behavioural and biochemical deficits: a parametric analysis","volume":"7","author":"Fredriksson","year":"1994","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"B82","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1600-0773.1994.tb00321.x","article-title":"Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice","volume":"75","author":"Fredriksson","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1600-0773.1990.tb00833.x","article-title":"MPTP-induced hypoactivity in mice: reversal by L-dopa","volume":"67","author":"Fredriksson","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1248\/bpb.28.169","article-title":"Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats","volume":"28","author":"Fujikawa","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"B86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","article-title":"Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity","volume":"123","author":"Gaugler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.7717\/peerj.1175","article-title":"A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease","volume":"3","author":"Geldenhuys","year":"2015","journal-title":"PeerJ"},{"key":"B88","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","article-title":"Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour","volume":"210","author":"George","year":"2008","journal-title":"Exp. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","article-title":"Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation","volume":"24","author":"Gispert","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS ONE"},{"key":"B91","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","article-title":"Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease","volume":"230","author":"Glajch","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp. Neurol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","article-title":"Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine","volume":"256","author":"Goes","year":"2014","journal-title":"Neuroscience"},{"key":"B94","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"key":"B96","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","article-title":"Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice","volume":"24","author":"Gomez-Isla","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B97","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/bs11050074","article-title":"Cognitive impairment in Parkinson's disease: epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav. Sci."},{"key":"B98","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60761-303-9_1","article-title":"\u201cThe open field test,\u201d","author":"Gould","year":"2009","journal-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","article-title":"Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior","volume":"88","author":"Graham","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0304-3940(86)90573-2","article-title":"Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults","volume":"70","author":"Gupta","year":"1986","journal-title":"Neurosci. Lett."},{"key":"B101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2008-2231-22-38","article-title":"Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study","volume":"22","author":"Haddadi","year":"2014","journal-title":"Daru"},{"key":"B102","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/dneu.20978","article-title":"Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice","volume":"72","author":"Hamill","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00222890903272025","article-title":"Treadmill gait analysis characterizes gait alterations in Parkinson's disease and amyotrophic lateral sclerosis mouse models","volume":"42","author":"Hampton","year":"2010","journal-title":"J. Mot. Behav."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Arch. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"111024","DOI":"10.1016\/j.brainresbull.2024.111024","article-title":"Advances in animal models of Parkinson's disease","volume":"215","author":"He","year":"2024","journal-title":"Brain Res. Bull."},{"key":"B106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","volume":"7","author":"Hinkle","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"B107","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbr.2014.04.022","article-title":"Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model","volume":"268","author":"Ho","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e1832","DOI":"10.1038\/cddis.2015.194","article-title":"Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons","volume":"6","author":"Hong","year":"2015","journal-title":"Cell Death Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","article-title":"AAV1\/2-induced overexpression of A53T-alpha-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease","volume":"5","author":"Ip","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lfs.2015.01.022","article-title":"Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease","volume":"125","author":"Issy","year":"2015","journal-title":"Life Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e91641","DOI":"10.1371\/journal.pone.0091641","article-title":"Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice","volume":"9","author":"Jia","year":"2014","journal-title":"PLoS ONE"},{"key":"B115","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.gendis.2023.03.017","article-title":"CRISPR\/Cas9 system and its applications in nervous system diseases","volume":"11","author":"Jiang","year":"2024","journal-title":"Genes Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"Neurotoxicology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/hep.21180","article-title":"Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis","volume":"43","author":"Jover","year":"2006","journal-title":"Hepatology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"B119","doi-asserted-by":"publisher","first-page":"223","DOI":"10.14336\/AD.2020.0331","article-title":"Comprehensive perspectives on experimental models for Parkinson's disease","volume":"12","author":"Ke","year":"2021","journal-title":"Aging Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.002","article-title":"Characterization of early-onset motor deficits in the Pink1-\/- mouse model of Parkinson disease","volume":"1680","author":"Kelm-Nelson","year":"","journal-title":"Brain Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2018.02.027","article-title":"Quantitative analysis of catecholamines in the Pink1 -\/- Rat model of early-onset Parkinson's disease","volume":"379","author":"Kelm-Nelson","year":"","journal-title":"Neuroscience"},{"key":"B123","doi-asserted-by":"publisher","first-page":"9088","DOI":"10.3390\/ijms24109088","article-title":"Parkinson's disease: exploring different animal model systems","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40478-018-0538-9","article-title":"D409H GBA1 mutation accelerates the progression of pathology in A53T alpha-synuclein transgenic mouse model","volume":"6","author":"Kim","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B126","first-page":"39","article-title":"Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv. Neurol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awm239","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"B128","unstructured":"\u201cAnimal models of Parkinson's disease,\u201d\n          \n          \n            \n              Konnova\n              E. A.\n            \n            \n              Swanberg\n              M.\n            \n          \n          Parkinson's Disease: Pathogenesis and Clinical Aspects\n          \n          2018"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"Koprich","year":"2011","journal-title":"PLoS ONE"},{"key":"B130","doi-asserted-by":"publisher","first-page":"16522","DOI":"10.1523\/JNEUROSCI.2545-13.2013","article-title":"Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation","volume":"33","author":"Kucinski","year":"2013","journal-title":"J. Neurosci."},{"key":"B131","first-page":"388","article-title":"Amphetamine attenuates the stimulated release of dopamine in vivo","volume":"232","author":"Kuhr","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B132","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.parkreldis.2004.02.001","article-title":"Visual object recognition deficits in early Parkinson's disease","volume":"10","author":"Laatu","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"B133","doi-asserted-by":"publisher","first-page":"49082","DOI":"10.1242\/dmm.049082","article-title":"The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease","volume":"15","author":"Landau","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"B134","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2015.06.018","article-title":"The combination of lithium and l-Dopa\/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinsons disease therapy","volume":"1622","author":"Lazzara","year":"2015","journal-title":"Brain Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0028-3932(97)00017-1","article-title":"Impairments of mental rotation in Parkinson's disease","volume":"36","author":"Lee","year":"1998","journal-title":"Neuropsychologia"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/brain\/123.7.1365","article-title":"Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"123","author":"Lee","year":"2000","journal-title":"Brain"},{"key":"B138","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurobiolaging.2014.07.011","article-title":"Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats","volume":"36","author":"Lee","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B139","doi-asserted-by":"publisher","first-page":"987084","DOI":"10.4061\/2011\/987084","article-title":"Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease","volume":"2011","author":"Lelan","year":"2011","journal-title":"Parkinsons Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e0117190","DOI":"10.1371\/journal.pone.0117190","article-title":"DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS","volume":"10","author":"Lev","year":"2015","journal-title":"PLoS ONE"},{"key":"B141","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00002093-199040300-00004","article-title":"Spatial cognition in Parkinson disease","volume":"4","author":"Levin","year":"1990","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B142","doi-asserted-by":"publisher","first-page":"181","DOI":"10.31887\/DCNS.2017.19.2\/wcarlezon","article-title":"Behavioral methods to study anxiety in rodents","volume":"19","author":"Lezak","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pbb.2005.09.004","article-title":"Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice","volume":"82","author":"Li","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1141567","DOI":"10.3389\/fnins.2023.1141567","article-title":"Non-human primate models and systems for gait and neurophysiological analysis","volume":"17","author":"Liang","year":"2023","journal-title":"Front. Neurosci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1523\/JNEUROSCI.4051-15.2017","article-title":"LRRK2 G2019S induces anxiety\/depression-like behavior before the onset of motor dysfunction with 5-HT1A receptor upregulation in mice","volume":"38","author":"Lim","year":"2018","journal-title":"J. Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J. Neurosci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0166-4328(96)02240-1","article-title":"Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task","volume":"86","author":"Lindner","year":"1997","journal-title":"Behav. Brain Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"B149","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease","volume":"129","author":"Liu","year":"","journal-title":"Acta Neuropathol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00702-017-1819-3","article-title":"An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice","volume":"125","author":"Liu","year":"2018","journal-title":"J. Neural. Transm."},{"key":"B152","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"303","author":"Liu","year":"","journal-title":"Neuroscience"},{"key":"B153","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","article-title":"Environment-contact administration of rotenone: a new rodent model of Parkinson's disease","volume":"294","author":"Liu","year":"","journal-title":"Behav. Brain Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J. Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"126769","DOI":"10.1172\/jci.insight.126769","article-title":"Age-dependent nigral dopaminergic neurodegeneration and alpha-synuclein accumulation in RGS6-deficient mice","volume":"5","author":"Luo","year":"2019","journal-title":"JCI Insight"},{"key":"B158","first-page":"943","article-title":"Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method","volume":"30","author":"Madiha","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"967813","DOI":"10.3389\/fncel.2022.967813","article-title":"Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson's disease rat model","volume":"16","author":"Magdy","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","article-title":"Genetic mouse models of Parkinson's disease The state of the art","volume":"184","author":"Magen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e3337","DOI":"10.21769\/BioProtoc.3337","article-title":"Cylinder test to assess sensory-motor function in a mouse model of Parkinson's disease","volume":"9","author":"Magno","year":"2019","journal-title":"Bio Protoc"},{"key":"B162","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-2859-6_12","article-title":"\u201cIn vivo animal models development and their limitations for brain research,\u201d","author":"Mangrulkar","year":"2024","journal-title":"Application of Nanocarriers in Brain Delivery of Therapeutics"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological alpha-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"B165","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1212\/WNL.32.5.567","article-title":"\u201cTip-of-the-tongue\u201d phenomenon in Parkinson disease","volume":"32","author":"Matison","year":"1982","journal-title":"Neurology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/ijms222111530","article-title":"Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response","volume":"22","author":"Mendes-Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"375462","DOI":"10.4061\/2010\/375462","article-title":"Spinal cord pathology in alpha-synuclein transgenic mice","volume":"2010","author":"Mendritzki","year":"2010","journal-title":"Parkinsons Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Parkinsons. Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"55523","DOI":"10.3791\/55523","article-title":"Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-beta and tau neuropathology","volume":"123","author":"Miedel","year":"2017","journal-title":"J. Vis. Exp"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1007\/s12035-017-0559-6","article-title":"MPTP mouse model of preclinical and clinical Parkinson's disease as an instrument for translational medicine","volume":"55","author":"Mingazov","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"212706","DOI":"10.4061\/2011\/212706","article-title":"alpha-synuclein transgenic drosophila as a model of Parkinson's disease and related synucleinopathies","volume":"2011","author":"Mizuno","year":"2010","journal-title":"Parkinsons Dis."},{"key":"B173","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1037\/h0043788","article-title":"The relation between fear induced by novel stimulation and exploratory behavior","volume":"48","author":"Montgomery","year":"1955","journal-title":"J. Comp. Physiol. Psychol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jneumeth.2006.06.001","article-title":"Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model","volume":"158","author":"Monville","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/nn.4641","article-title":"Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration","volume":"20","author":"Mor","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"Morais","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00702-017-1722-y","article-title":"Non-human primate models of PD to test novel therapies","volume":"125","author":"Morissette","year":"2018","journal-title":"J. Neural Transm."},{"key":"B178","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"B179","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.12.011","article-title":"Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-alpha-synuclein and the pesticide, rotenone","volume":"203","author":"Mulcahy","year":"2012","journal-title":"Neuroscience"},{"key":"B180","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuroscience.2011.01.038","article-title":"Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone","volume":"181","author":"Mulcahy","year":"2011","journal-title":"Neuroscience"},{"key":"B181","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neures.2019.12.009","article-title":"Understanding the circuit basis of cognitive functions using mouse models","volume":"152","author":"Nakajima","year":"2020","journal-title":"Neurosci. Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbr.2015.09.025","article-title":"Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease","volume":"296","author":"Naughton","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbr.2016.08.056","article-title":"Interaction between subclinical doses of the Parkinson's disease associated gene, alpha-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats","volume":"316","author":"Naughton","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12906-022-03524-1","article-title":"Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress","volume":"22","author":"Nourmohammadi","year":"2022","journal-title":"BMC Complement. Med. Ther."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e60378","DOI":"10.1371\/journal.pone.0060378","article-title":"Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function","volume":"8","author":"Oaks","year":"2013","journal-title":"PLoS ONE"},{"key":"B186","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"B187","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000116351","article-title":"MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior","volume":"26","author":"Ogawa","year":"1987","journal-title":"Eur. Neurol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.neuropharm.2008.11.004","article-title":"Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of L-DOPA","volume":"56","author":"Oksman","year":"2009","journal-title":"Neuropharmacology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-8-44","article-title":"rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"Oliveras-Salva","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2016.04.004","article-title":"Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice","volume":"110","author":"Palomo-Garo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B193","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF02244188","article-title":"An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress","volume":"104","author":"Papp","year":"1991","journal-title":"Psychopharmacology"},{"key":"B194","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5607\/en.2016.25.4.174","article-title":"Palmitoyl serotonin inhibits L-dopa-induced abnormal involuntary movements in the mouse Parkinson model","volume":"25","author":"Park","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease","volume":"8","author":"Paumier","year":"2013","journal-title":"PLoS ONE"},{"key":"B196","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of parkinsonism","volume":"102","author":"Perez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142301.ns1001s49","article-title":"Assessment of Parkinson disease manifestations","volume":"10","author":"Perlmutter","year":"2009","journal-title":"Curr Protoc Neurosci, Chapter"},{"key":"B199","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","article-title":"Early synaptic dysfunction induced by alpha-synuclein in a rat model of Parkinson's disease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"key":"B200","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1523\/JNEUROSCI.1384-17.2017","article-title":"Lack of parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson's disease","volume":"38","author":"Pinto","year":"2018","journal-title":"J. Neurosci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/brain\/awab073","article-title":"LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation","volume":"144","author":"Pischedda","year":"2021","journal-title":"Brain"},{"key":"B203","doi-asserted-by":"publisher","first-page":"28","DOI":"10.11138\/FNeur\/2017.32.1.028","article-title":"Gait analysis and clinical correlations in early Parkinson's disease","volume":"32","author":"Pistacchi","year":"2017","journal-title":"Funct. Neurol."},{"key":"B204","first-page":"205","article-title":"Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice","volume":"59","author":"Plaas","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1100\/2011\/172893","article-title":"Serotonergic dysfunction in Parkinson's disease and its relevance to disability","volume":"11","author":"Politis","year":"2011","journal-title":"Scien. World J."},{"key":"B206","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"323","author":"Putterman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1223747","DOI":"10.3389\/fnins.2023.1223747","article-title":"Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease","volume":"17","author":"Qu","year":"2023","journal-title":"Front. Neurosci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/bjp.2008.78","article-title":"The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B","volume":"154","author":"Quinn","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneumeth.2007.03.021","article-title":"A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl","volume":"164","author":"Quinn","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"B213","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1007\/s12035-023-03485-7","article-title":"Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice","volume":"60","author":"Ramirez-Carreto","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/pm.pm_113_17","article-title":"Demethoxycurcumin, a natural derivative of curcumin abrogates rotenone-induced dopamine depletion and motor deficits by its antioxidative and anti-inflammatory properties in parkinsonian rats","volume":"14","author":"Ramkumar","year":"2018","journal-title":"Pharmacogn. Mag."},{"key":"B215","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41586-023-06683-4","article-title":"Neural signal propagation atlas of Caenorhabditis elegans","volume":"623","author":"Randi","year":"2023","journal-title":"Nature"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"B217","doi-asserted-by":"publisher","first-page":"e114216","DOI":"10.1371\/journal.pone.0114216","article-title":"Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease","volume":"9","author":"Rial","year":"2014","journal-title":"PLoS ONE"},{"key":"B218","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2016.11.015","article-title":"Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat\/maneb toxicity in mice","volume":"51","author":"Richter","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B219","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jnr.21159","article-title":"Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice","volume":"85","author":"Richter","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"B220","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2007.07.022","article-title":"Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats","volume":"208","author":"Rojo","year":"2007","journal-title":"Exp. Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice","volume":"104","author":"Rommelfanger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B222","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","article-title":"Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice","volume":"14","author":"Rousselet","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"B223","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","article-title":"An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism","volume":"2","author":"Rozas","year":"1997","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"B224","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0006-8993(96)01162-6","article-title":"Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test","volume":"749","author":"Rozas","year":"1997","journal-title":"Brain Res."},{"key":"B225","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0165-0270(98)00078-8","article-title":"The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism","volume":"83","author":"Rozas","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"B226","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-8993(86)91401-0","article-title":"Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease","volume":"362","author":"Ruberg","year":"1986","journal-title":"Brain Res."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B228","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-4886(79)90003-7","article-title":"Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism","volume":"64","author":"Schallert","year":"1979","journal-title":"Exp. Neurol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2017.01.010","article-title":"The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future","volume":"37","author":"Schilder","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B231","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF03033338","article-title":"Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease","volume":"1","author":"Schwarting","year":"1999","journal-title":"Neurotox. Res."},{"key":"B233","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fnins.2020.00674","article-title":"Progress in LRRK2-associated Parkinson's disease animal models","volume":"14","author":"Seegobin","year":"2020","journal-title":"Front. Neurosci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"e52434","DOI":"10.3791\/52434-v","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","volume":"2015","author":"Seibenhener","year":"2015","journal-title":"J Vis Exp."},{"key":"B235","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.7717\/peerj.945","article-title":"Transgenic LRRK2 (R1441G) rats-a model for Parkinson disease?","volume":"3","author":"Shaikh","year":"2015","journal-title":"PeerJ"},{"key":"B236","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pathophys.2016.03.002","article-title":"Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats","volume":"23","author":"Sharma","year":"2016","journal-title":"Pathophysiology"},{"key":"B237","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"key":"B239","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"B240","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","article-title":"Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats","volume":"622","author":"Silva","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B241","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/294475a0","article-title":"Persistent behavioural effect in apomorphine in 6-hydroxydopamine-lesioned rats","volume":"294","author":"Silverman","year":"1981","journal-title":"Nature"},{"key":"B242","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","article-title":"Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions","volume":"61","author":"Simon","year":"1994","journal-title":"Behav. Brain Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"970354","DOI":"10.1155\/2015\/970354","article-title":"Protective effects of streblus asper leaf extract on H2O2-induced ROS in SK-N-SH cells and MPTP-induced Parkinson's disease-like symptoms in C57BL\/6 mouse","volume":"2015","author":"Singsai","year":"2015","journal-title":"Evid. Based Complem. Alternat. Med."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jnbs.jnbs_1_22","article-title":"Motor function test protocol for parkinsonian triad in rodent model of Parkinson's disease","volume":"9","author":"Sirajo","year":"2022","journal-title":"J. Neurobehavioral Sci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jnc.15588","article-title":"LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons","volume":"161","author":"Skiteva","year":"2022","journal-title":"J. Neurochem."},{"key":"B246","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology"},{"key":"B247","doi-asserted-by":"publisher","first-page":"19478","DOI":"10.1038\/s41598-023-46576-0","article-title":"Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease","volume":"13","author":"Slezia","year":"2023","journal-title":"Sci. Rep."},{"key":"B248","doi-asserted-by":"publisher","first-page":"e0131281","DOI":"10.1371\/journal.pone.0131281","article-title":"Targeted overexpression of alpha-synuclein by rAAV2\/1 vectors induces progressive nigrostriatal degeneration and increases vulnerability to MPTP in mouse","volume":"10","author":"Song","year":"2015","journal-title":"PLoS ONE"},{"key":"B249","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J. Neurosci."},{"key":"B250","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"B251","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/j.1471-4159.1991.tb06407.x","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities","volume":"57","author":"Tasaki","year":"1991","journal-title":"J. Neurochem."},{"key":"B253","doi-asserted-by":"publisher","first-page":"51785","DOI":"10.3791\/51785-v","article-title":"Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases","volume":"91","author":"Tatem","year":"2014","journal-title":"J. Vis. Exp."},{"key":"B254","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-016-0310-y","article-title":"Fasudil attenuates aggregation of alpha-synuclein in models of Parkinson's disease","volume":"4","author":"Tatenhorst","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","article-title":"Behavioral phenotyping of mouse models of Parkinson's disease","volume":"211","author":"Taylor","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1742-4658.2008.06302.x","article-title":"Parkinson's disease: genetic versus toxin-induced rodent models","volume":"275","author":"Terzioglu","year":"2008","journal-title":"FEBS J."},{"key":"B257","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","article-title":"Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?","volume":"873","author":"Thiruchelvam","year":"","journal-title":"Brain Res."},{"key":"B258","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B259","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"","journal-title":"J. Neurosci."},{"key":"B260","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0161-813X(02)00092-X","article-title":"Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype","volume":"23","author":"Thiruchelvam","year":"2002","journal-title":"Neurotoxicology"},{"key":"B261","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1523\/JNEUROSCI.21-12-04427.2001","article-title":"Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine","volume":"21","author":"Tillerson","year":"2001","journal-title":"J. Neurosci."},{"key":"B263","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2015.10.021","article-title":"The impact of paraquat\/maneb intoxication and the selective depletion of monoamines on the motor and circadian systems: behavioral, biochemical and electrophysiological studies in the context of Parkinson's disease","volume":"311","author":"Tinakoua","year":"2015","journal-title":"Neuroscience"},{"key":"B264","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1093\/brain\/aws254","article-title":"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease","volume":"135","author":"Tonges","year":"2012","journal-title":"Brain"},{"key":"B265","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neures.2012.03.004","article-title":"Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study","volume":"73","author":"Tronci","year":"2012","journal-title":"Neurosci. Res."},{"key":"B266","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B267","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","article-title":"Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice","volume":"21","author":"Unger","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B268","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"B270","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","article-title":"Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease","volume":"14","author":"Vercammen","year":"2006","journal-title":"Mol. Ther."},{"key":"B271","doi-asserted-by":"publisher","first-page":"111981","DOI":"10.1016\/j.bbr.2019.111981","article-title":"Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety","volume":"371","author":"Vieira","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B272","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2014.11.002","article-title":"The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings","volume":"279","author":"Von Wrangel","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030579","article-title":"The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease","author":"Vos","year":"2021","journal-title":"Cells"},{"key":"B274","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0028-3908(79)90119-9","article-title":"Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding","volume":"18","author":"Waddington","year":"1979","journal-title":"Neuropharmacology"},{"key":"B275","doi-asserted-by":"publisher","first-page":"26285","DOI":"10.1038\/srep26285","article-title":"alpha-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"B276","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fnagi.2017.00331","article-title":"Levodopa\/benserazide loaded microspheres alleviate L-dopa induced dyskinesia through preventing the over-expression of D1R\/Shp-2\/ERK1\/2 signaling pathway in a rat model of Parkinson's disease","volume":"9","author":"Wan","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B277","doi-asserted-by":"publisher","first-page":"1367973","DOI":"10.3389\/fneur.2024.1367973","article-title":"Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson's rats","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Neurol."},{"key":"B278","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"","journal-title":"Neurogastroenterol. Motil."},{"key":"B279","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0269881108089814","article-title":"Anhedonia and activity deficits in rats: impact of post-stroke depression","volume":"23","author":"Wang","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"B280","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2202-13-142","article-title":"Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease","volume":"13","author":"Wang","year":"","journal-title":"BMC Neurosci."},{"key":"B281","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1074\/jbc.M110.208447","article-title":"Alternative mitochondrial electron transfer as a novel strategy for neuroprotection","volume":"286","author":"Wen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B282","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0165-0270(03)00049-9","article-title":"Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking","volume":"126","author":"Whishaw","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"B283","doi-asserted-by":"publisher","first-page":"e0147733","DOI":"10.1371\/journal.pone.0147733","article-title":"A comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice","volume":"11","author":"Wolf","year":"2016","journal-title":"PLoS ONE"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0004-17.2017","article-title":"Overexpression of Parkinson's disease-associated mutation LRRK2 G2019S in mouse forebrain induces behavioral deficits and alpha-synuclein pathology","author":"Xiong","year":"2017","journal-title":"eNeuro"},{"key":"B285","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fneur.2018.00228","article-title":"Modeling Parkinson's disease in drosophila: what have we learned for dominant traits?","volume":"9","author":"Xiong","year":"2018","journal-title":"Front. Neurol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"816331","DOI":"10.3389\/fnins.2022.816331","article-title":"Functional connectivity of the brain across rodents and humans","volume":"16","author":"Xu","year":"2022","journal-title":"Front. Neurosci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.11.051","article-title":"Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice","volume":"259","author":"Yabuki","year":"2014","journal-title":"Neuroscience"},{"key":"B288","doi-asserted-by":"publisher","first-page":"e0182092","DOI":"10.1371\/journal.pone.0182092","article-title":"Quantitative proteomics in A30P*A53T alpha-synuclein transgenic mice reveals upregulation of Sel1l","volume":"12","author":"Yan","year":"2017","journal-title":"PLoS ONE"},{"key":"B289","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.nbd.2005.03.010","article-title":"Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein","volume":"20","author":"Yavich","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B290","doi-asserted-by":"publisher","first-page":"e21125","DOI":"10.1016\/j.heliyon.2023.e21125","article-title":"Application of serum peptidomics for Parkinson's disease in SNCA-A30P mice","volume":"9","author":"Yin","year":"2023","journal-title":"Heliyon"},{"key":"B291","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/0253-7613.103300","article-title":"Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats","volume":"44","author":"Zaitone","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1759091418777438","DOI":"10.1177\/1759091418777438","article-title":"Neurotoxin-induced animal models of parkinson disease: pathogenic mechanism and assessment","volume":"10","author":"Zeng","year":"2018","journal-title":"ASN Neuro"},{"key":"B293","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1109\/TBCAS.2011.2177089","article-title":"Design of ultra-low power biopotential amplifiers for biosignal acquisition applications","volume":"6","author":"Zhang","year":"2012","journal-title":"IEEE Trans. Biomed. Circuits Syst."},{"key":"B294","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-023-01549-0","article-title":"Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson's disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov."},{"key":"B295","doi-asserted-by":"publisher","first-page":"9450137","DOI":"10.1155\/2016\/9450137","article-title":"Neuroprotective effects of salidroside in the MPTP mouse model of parkinson's disease: involvement of the PI3K\/Akt\/GSK3beta pathway","volume":"2016","author":"Zhang","year":"2016","journal-title":"Parkinsons Dis."},{"key":"B296","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/ijbs.3.242","article-title":"Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice","volume":"3","author":"Zhou","year":"2007","journal-title":"Int. J. Biol. Sci."},{"key":"B297","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2014.10.032","article-title":"Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease","volume":"584","author":"Zhou","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B298","doi-asserted-by":"publisher","first-page":"32206","DOI":"10.1038\/srep32206","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"B299","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","article-title":"Non-motor behavioural impairments in parkin-deficient mice","volume":"26","author":"Zhu","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B300","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/antiox12051134","article-title":"JAC4 alleviates rotenone-induced Parkinson's disease through the inactivation of the NLRP3 signal pathway","volume":"12","author":"Zou","year":"2023","journal-title":"Antioxidants"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1464706\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:43:23Z","timestamp":1734918203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1464706\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":300,"alternative-id":["10.3389\/fnagi.2024.1464706"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1464706","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"article-number":"1464706"}}